Application
18572863 · HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
Filed 2023-12-21 · Granted · Patent 12655129 (2026-06-16) The official file ↗The patent and its PDF ↗ · Art unit 1623 · Examiner Yong Soo Chong Typical · CPC C07D 401/14 · Blueprint Medicines Corporation · MCCARTER & ENGLISH, LLP BOSTON
Office actions
0
first was Notice of allowance
RCEs
0
no appeal
To first action
25.8 mo
to disposition 29.8 mo
Statutes raised
·
0 actions read